Stephens analyst Scott Fidel raised the firm’s price target on Tenet Healthcare to $122 from $95 and keeps an Equal Weight rating on the shares. Tenet’s portfolio transformation initiative “assumed the spotlight” in Q1, positioning the business towards a more capital efficient and profitable enterprise, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC: